Risk of second primary melanoma up in pediatric patients

This article originally appeared here.
Share this content:
Risk of Second Primary Melanoma Up in Pediatric Patients
Risk of Second Primary Melanoma Up in Pediatric Patients

(HealthDay News) -- Pediatric patients diagnosed with an invasive cutaneous melanoma have nearly double the relative risk of developing a subsequent primary melanoma, compared with adults, according to a study published online June 20 in the British Journal of Dermatology.

To investigate the risks of subsequent primary melanoma development in pediatric and adult patients, G. W. Jung, of the University of Alberta in Edmonton, Canada, and Martin A. Weinstock, M.D., Ph.D., of Rhode Island Hospital in Providence, conducted a retrospective study using data from the Surveillance, Epidemiology and End Results database for 208,289 patients diagnosed with invasive melanoma from 1973 to 2010.

The researchers found that 3.3 percent of patients were diagnosed with a subsequent primary melanoma. Increasing age at diagnosis of the first melanoma correlated with increasing incidence of second primary melanomas. However, patients diagnosed with their first melanoma at age 19 years or younger had nearly double the relative risk of developing a subsequent melanoma compared to those who were first diagnosed when they were older. Forty-four percent of subsequent melanomas were of a different subtype to the initial invasive melanoma, and 55 percent were located in a different anatomic site compared with the initial invasive melanoma.

"In summary, second primary melanoma is not only an important sequelae of adult melanomas but also a significant consequence following pediatric index cases," the authors write. "As such, both physicians and parents should maintain a proactive follow-up regimen consisting of regular complete skin examinations for this younger patient population, as should occur with other age groups."

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs